. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Int J Drug Policy. 2020 Oct 7;86:102971. doi: 10.1016/j.drugpo.2020.102971

Table 6.

Differences in cannabis product type by purchasing patterns

	Joint	Blunt	Pipe	Bong	Dabs	Edible	Vape	Beverage	Total Products
Model 1
Intercept	0.46 p<.01	0.40 p<.01	0.33 p<.01	0.24 p<.01	0.11 p<.01	0.24 p<.01	0.42 p<.01	0.04 p=.06	2.21 p<.01
Total Sources Types^#	0.10^* p<.01	0.03 p=.23	0.12^* p<.01	0.15^* p<.01	0.09^* p<.01	0.06^* p=.01	0.09^* p<.01	0.03^* p=.04	0.69^* p<.01
Model 2
Family/Friend (ref)	0.52 p<.01	0.35 p<.01	0.40 p<.01	0.28 p<.01	0.10 p<.01	0.25 p<.01	0.42 p<.01	0.04 p=.02	2.35 p<.01
Medical Cannabis Dispensary	0.69^* p<.01	0.55^* p<.01	0.55^* p<.01	0.53^* p<.01	0.37^* p<.01	0.32^* p=.05	0.61^* p<.01	0.15^* p<.01	3.74^* p<.01
Recreational Cannabis Retailer	0.60^* p=.04	0.39 p=.27	0.50^* p=.01	0.43^* p<.01	0.19^* p=.01	0.34^* p=.01	0.54^* p<.01	0.06 p=.28	3.04^* p<.01
Stranger/Dealer	0.68^* p=.04	0.38 p=.72	0.48 p=.29	0.49^* p=.01	0.04 p=.36	0.32 p=.31	0.38 p=.63	0.04 p=.92	2.81 p=.13

Note. Model 1 coefficients are estimates from regression with slopes denoted (^#). Model 2 are actual proportions for each group computed from regression coefficients. Significant differences in Model 2 reflect differences with the reference group (i.e., Family/Friend sources of cannabis). All significant effects are at p<.05 and denoted (*). Statistical significance (p-value) is also presented for the reference groups (i.e., intercept) to indicate whether the estimate is significantly different from zero.